Thursday, November 15, 2012

• Speculators Find Loopholes in French Transaction Taxat Bloomberg (Thu, Nov 15)

Tuesday, November 13, 2012

• Genzyme Announces Return to Full Supply of Thyrogen (thyrotropin alfa for injection)Business Wire (Tue, Nov 13)

Sunday, November 11, 2012

• Advil Ingredient Maker Sees Patent Expiry Boom: Corporate Indiaat Bloomberg (Sun, Nov 11)

Friday, November 9, 2012

• Novo Aims for Tresiba U.S. Approval in First Half of 2013at Bloomberg (Fri, Nov 9)
• Sanofi and Genzyme Congratulate the 2012 Schwartz Center Compassionate Caregiver Award WinnerBusiness Wire (Fri, Nov 9)

Wednesday, November 7, 2012

• Credit Risk Falls as Greek Optimism Adds to Obama’s U.S. Victoryat Bloomberg (Wed, Nov 7)

Tuesday, November 6, 2012

• Novo’s Insulin Tresiba Has Heart Safety Risks, FDA Saysat Bloomberg (Tue, Nov 6)
• Amgen’s Heart Drug Lowers Patient Cholesterol in Studyat Bloomberg (Tue, Nov 6)

Monday, November 5, 2012

• Amgen’s Drug Lowers Cholesterol Among Statin Intolerantat Bloomberg (Mon, Nov 5)
• China Diabetes Triples Creating $3.2 Billion Drug Marketat Bloomberg (Mon, Nov 5)

Friday, November 2, 2012

• Amgen Bets on Heart Drug as Rivals Aim at Sales: Healthat Bloomberg (Fri, Nov 2)

Wednesday, October 31, 2012

• Sanofi Worm Pill Kills Resistant Head Lice as a Lotionat Bloomberg (Wed, Oct 31)
• Glaxo Profit Misses Estimates as Pricing Hurts Europe Salesat Bloomberg (Wed, Oct 31)
• Snake Farm Feels Bite as Drugmakers Cut Ordersat Bloomberg (Wed, Oct 31)

Friday, October 26, 2012

• Novo Nordisk Falls as FDA Panel to Discuss Insulin Risksat Bloomberg (Fri, Oct 26)

Thursday, October 25, 2012

• European Stocks Rise as Unilever, Sanofi Beat Estimatesat Bloomberg (Thu, Oct 25)
• Sanofi Narrows Full-Year Forecast as Quarterly Profit Dropsat Bloomberg (Thu, Oct 25)

Friday, October 19, 2012

• Vivus Obesity Drug Fails to Win European Agency Backingat Bloomberg (Fri, Oct 19)
• Novo Nordisk Wins EU Panel’s Recommendation for Tresibaat Bloomberg (Fri, Oct 19)

Thursday, October 18, 2012

• Aegerion Drug Wins Panel Support for Cholesterol Diseaseat Bloomberg (Thu, Oct 18)
• Biogen Idec Says FDA Extends MS Drug Reviewat Bloomberg (Thu, Oct 18)

Wednesday, October 17, 2012

• Retirement No Option for Older Workers in Europe’s Crisisat Bloomberg (Wed, Oct 17)

Tuesday, October 16, 2012

• Isis Falls on Concerns Over Abnormal Growths With Kynamroat Bloomberg (Tue, Oct 16)
• Vivendi, STMicro Revamp Face Hollande’s Scrutiny Over Jobsat Bloomberg (Tue, Oct 16)

Monday, October 15, 2012

• Aegerion Shares Rise on Report of High Cholesterol Drugat Bloomberg (Mon, Oct 15)

Add SAN.PA News to My Yahoo!